These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16341270)

  • 1. The synthesis, physicochemical properties and immunological activity of 5-amino-3-methylisoxazolo[5,4-d]4-pyrimidinone derivatives.
    Maczyński M; Zimecki M; Drozd-Szczygieł E; Ryng S
    Cell Mol Biol Lett; 2005; 10(4):613-23. PubMed ID: 16341270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New derivatives of 5-amino-3-methyl-4-isothiazolecarboxylic acid and their immunological activity.
    Lipnicka U; Zimecki M
    Acta Pol Pharm; 2007; 64(3):233-40. PubMed ID: 17695146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and immunomodulatory activites of new 5-hydrazino-3-methyl-4-isothiazolecarboxylic acid ethyl esters.
    Lipnicka U; Maczyński M; Artym J; Zimecki M
    Acta Pol Pharm; 2009; 66(5):501-11. PubMed ID: 19894646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and immunological activity of new 5-amino-3-methyl 4-amido and 4-ureilene isoxazole derivatives.
    Ryng S; Machoń Z; Wieczorek Z; Zimecki M
    Pharmazie; 1999 May; 54(5):359-61. PubMed ID: 10368829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotropic activity of vratizolin (ITCL, Denotivir).
    Machoń Z; Wieczorek Z; Zimecki M
    Pol J Pharmacol; 2001; 53(4):377-83. PubMed ID: 11990084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New amides of 5-acylamino-3-methyl-4-isothiazolecarboxylic acid and their immunotropic activity.
    Lipnicka U; Regiec A; Sułkowski E; Zimecki M
    Arch Pharm (Weinheim); 2005 Jul; 338(7):322-8. PubMed ID: 15952244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis and interferon-inducing activity studies on the antiviral compounds of 2,5,6-trisubstituted-4(3H) pyrimidinone derivatives].
    Liu XY; Xu LJ
    Yao Xue Xue Bao; 1994; 29(2):153-7. PubMed ID: 8042514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of the stimulatory capacity of pokeweed mitogen via its binding to autologous erythrocytes.
    Uiterdijk HG; Doekes G; de Vreede TM; de Vries E; Cats A
    Int Arch Allergy Appl Immunol; 1989; 88(4):447-53. PubMed ID: 2722260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for new lead structures for low-molecular-weight immune response modifiers.
    Ryng S; Zimecki M
    Acta Pol Pharm; 2004 Dec; 61 Suppl():78-81. PubMed ID: 15909948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro modulation of interleukin-2-mediated human peripheral mononuclear cell proliferation and antitumor cytotoxicity by 5-fluorouracil.
    Brazowski E; Eytan K; Eisenthal A
    Anticancer Res; 2007; 27(6B):4135-41. PubMed ID: 18225584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory properties of an isoxazole derivative - MZO-2.
    Mączyński M; Artym J; Kocięba M; Kochanowska I; Ryng S; Zimecki M
    Pharmacol Rep; 2016 Oct; 68(5):894-902. PubMed ID: 27351945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, immunological activity and theoretical study of new 5-substituted 3-methylisoxazole[5,4-d] 1,2,3-triazin-4-one derivatives.
    Maczyński M; Jezierska A; Zimecki M; Ryng S
    Acta Pol Pharm; 2003; 60(2):147-50. PubMed ID: 13678327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure/activity investigations of 5-substituted 3-methylisoxazole[5, 4-d]1, 2, 3-triazin-4-one derivatives.
    Jezierska A; Maczyński M; Koll A; Ryng S
    Arch Pharm (Weinheim); 2004 Feb; 337(2):81-9. PubMed ID: 14981664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.
    Hertzog DL; Al-Barazanji KA; Bigham EC; Bishop MJ; Britt CS; Carlton DL; Cooper JP; Daniels AJ; Garrido DM; Goetz AS; Grizzle MK; Guo YC; Handlon AL; Ignar DM; Morgan RO; Peat AJ; Tavares FX; Zhou H
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4723-7. PubMed ID: 16870432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model.
    Panzenbeck MJ; Jeanfavre DD; Kelly TA; Lemieux R; Nabozny G; Reilly PL; Desai S
    Eur J Pharmacol; 2006 Mar; 534(1-3):233-40. PubMed ID: 16487962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactions of 5-amino-3-methylisoxazole-4-carboxylic acid hydrazide with carbonyl compounds: immunological activity and QSAR studies of products.
    Ryng S; Zimecki M; Fedorowicz A; Jezierska A
    Arch Pharm (Weinheim); 2001 Mar; 334(3):71-8. PubMed ID: 11315337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogenic properties of pokeweed lectin-D isoforms on human peripheral blood lymphocytes: non-mitogen PL-D1 and mitogen PL-D2.
    Yamaguchi K; Uechi M; Katakura Y; Oda T; Ishiguro M
    Biosci Biotechnol Biochem; 2004 Jul; 68(7):1591-3. PubMed ID: 15277769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d]pyrimidine 4',5'-didehydro-L-ascorbic acid derivatives.
    Gazivoda T; Sokcević M; Kralj M; Suman L; Pavelić K; De Clercq E; Andrei G; Snoeck R; Balzarini J; Mintas M; Raić-Malić S
    J Med Chem; 2007 Aug; 50(17):4105-12. PubMed ID: 17672445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular and humoral immunity in general exogenous hyperthermia].
    Solov'ev AS
    Patol Fiziol Eksp Ter; 1994; (2):31-3. PubMed ID: 8078688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 2-mercapto-3-substituted-5,6-dimethylthieno[2,3-d] pyrimidin-4(3H)-ones as new analgesic, anti-inflammatory agents.
    Alagarsamy V; Vijayakumar S; Raja Solomon V
    Biomed Pharmacother; 2007 Jun; 61(5):285-91. PubMed ID: 17391907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.